FFPE

Two researchers devised a protocol to sequence DNA from ancient samples and tested it on 100-year-old museum specimens.

The combination of the new test with Biocartis' existing KRAS assay offers customers a complete solution for testing metastatic colorectal cancers as reccomended by professional guidelines.

The company plans to raise $25 million in a Series B financing round. It is also working on a two-color chemistry and aims to develop an instrument for clinical applications.

The diagnostic, a real-time PCR kit for breast cancer stratification, is being reviewed under a special process for the approval of innovative products.

Earlier this month at AGBT, company researchers presented the new developments, which Thermo Fisher plans to roll out later this year.

They plan to combine Silicon’s DEPArray digital-sorting technology with Macrogen’s NGS systems to develop genomic tests for different cancers.

At the Festival of Genomics conference, experts discussed ongoing issues with developing NGS tests for the clinic, and how they are solving such challenges. 

This Week in Nature

In Nature this week: method to detect single-nucleotide and copy-number alterations in single cells from archival tissue, and more.

The team found that the capture-based approach is better than standard poly A RNA-seq at detecting gene expression, fusions, and SNVs from clinical samples.

The UCSF spinout was founded last year and has been selling an FFPE DNA extraction kit and three NGS cancer panels.

Pages

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.